[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632691":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":40,"collaborators":20,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":20,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":20,"enrollmentInfo":51,"targetDuration":20,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":62,"overallStatus":68,"whyStopped":20,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Daewoong Pharmaceutical Co. LTD.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Noseguard Combined Use","EXPERIMENTAL","Participants will use Noseguard during daytime activities and Noseguard Night before sleep for 8 weeks.",[13],"Device: Noseguard and Noseguard Night",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Noseguard and Noseguard Night","Nasal spray medical devices used to form a protective barrier on the nasal mucosa to reduce viral entry.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"SoHeui Kim","CONTACT","82-10-2994-5887","2210325@daewoong.co.kr",[28],{"facility":29,"status":20,"city":30,"state":20,"zip":20,"country":31,"countryCode":20,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Jeonbuk University Hospital","Jeonju","South Korea",{"type":33,"coordinates":34},"Point",[35,36],127.14889,35.82194,{"lat":36,"lon":35},[39],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"type":41,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100632691","noseguard-for-prevention-of-respiratory-infections-in-real-world-use-100632691",false,"NCT07516977","Noseguard for Prevention of Respiratory Infections in Real-World Use","A Clinical Study to Evaluate the Effectiveness of Combined Use of Two Nasal Protective Medical Devices (Noseguard and Noseguard Night) for Reducing Respiratory Infection Rates and Assessing Usability","Inclusion Criteria:\n\n* Adults aged ≥19 years\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Hypersensitivity to device components\n* Current COVID-19 or influenza infection\n* Severe nasal disease\n* Pregnant or breastfeeding women","ALL","19 Years",{"count":52,"type":53},2000,"ESTIMATED","INTERVENTIONAL",[56],"NA","This study is a prospective clinical study to evaluate the effectiveness of combined use of two nasal protective medical devices (Noseguard and Noseguard Night) in reducing respiratory infection rates, including COVID-19 and influenza, in real-world conditions.\n\nThe study will also assess usability, satisfaction, and safety using electronic patient-reported outcomes (ePRO).",[59,60,61],"Respiratory Infection Virus","COVID-19","Influenza",[63,64,65,66,67],"Nasal Spray","Medical Device","Infection prevention","ePRO","Real-World","NOT_YET_RECRUITING","2026-04-01",{"date":71,"type":72},"2026-04-08","ACTUAL",{"date":74,"type":53},"2026-04-20",{"date":76,"type":53},"2026-12-31",{"name":5,"class":6},1]